ARTICLE | Clinical News
HPV16L1E7CVLP: Began Phase I/II trial
November 6, 2000 8:00 AM UTC
MediGene AG (NMarkt:MDG), Munich, Germany Product: HPV16L1E7CVLP Business: Cancer Therapeutic category: Immune stimulation Target: Immune cells Description: Chimeric virus-like particle (CVLP) contain...